Al Qassimi Hospital, part of Emirates Health Services (EHS), has launched the latest coronary angiography program, ‘Ultreon 3.0’, a fourth-generation, high-resolution imaging technology that uses light and infrared light, marking a first in the Middle East.
The introduction of the Ultreon 3 program reflects EHS’ commitment to adopting advanced medical solutions aimed at enhancing diagnostic accuracy and improving the quality of cardiac care across the UAE.
Dr Arif Al-Nouriani, Executive Director and Head of the Heart Centre at Al Qassimi Hospital in Sharjah, confirmed that the introduction of the Ultreon 3.0 represents a qualitative leap in the diagnosis of coronary artery disease.
He explained that it offers the most advanced imaging accuracy globally for detecting arterial narrowing and hardening, and that Ultreon 3.0 combines light and infrared radiation, providing an unprecedentedly detailed view of the artery structure.
Dr. Al-Nouriani added that one of the program’s most prominent features is the ability to perform imaging without the need for contrast dye, along with the procedure’s speed of less than one second.
Dr. Al-Nouriani pointed out that the Ultreon 3.0 utilizes artificial intelligence technologies for advanced data analysis. It also determines the degree of arterial narrowing and measures physiological blood flow velocity with greater accuracy, reaching approximately 82 percent compared to traditional methods.
This allows for a comprehensive assessment that combines diagnostic imaging with functional analysis simultaneously, in addition to the ability to identify areas of fatty and calcified plaque buildup. This constitutes a true revolution in the diagnosis of heart and coronary artery disease.
The Heart Centre at Al Qassimi Hospital has begun using the new program, treating two Emirati patients, with initial results showing high levels of accuracy and efficiency. The program is expected to improve patient outcomes by reducing cardiac stent failure rates in both the short and long term, while also lowering mortality rates and hospital readmissions, ultimately enhancing patients’ quality of life.
The adoption of Ultreon 3.0 advanced program aligns with EHS strategy to develop specialized and precise healthcare services through the use of the latest medical innovations and smart technologies. The move further reinforces the UAE’s position as a leading regional hub for high-quality healthcare services.
